We've found
12,064 Hematology
clinical trials
Multiple Myeloma Clinical Trial
A Phase 1 Study of Ruxolitinib, Steroids and Lenalidomide for Relapsed/Refractory Multiple Myeloma (RRMM) Patients
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Clinical Evaluation of the OncAlert RAPID in Subjects Presenting for Evaluation and/or Initial Biopsy; Impact on Decision-Making
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
CAH - Congenital Adrenal Hyperplasia Clinical Trial
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of NBI-74788 in Adults With Congenital Adrenal Hyperplasia
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology Clinical Trial
A Research Study Looking at How a Factor VIII Medicine Called Turoctocog Alfa Pegol (N8-GP) Works in People With Haemophilia A
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology Clinical Trial
A Research Study Looking at How a Factor VIII Medicine Called Turoctocog Alfa Pegol (N8-GP) Works in People With Haemophilia A
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology Clinical Trial
A Research Study Looking at How a Factor VIII Medicine Called Turoctocog Alfa Pegol (N8-GP) Works in People With Haemophilia A
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology Clinical Trial
A Research Study Looking at How a Factor VIII Medicine Called Turoctocog Alfa Pegol (N8-GP) Works in People With Haemophilia A
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
A Study of JNJ-68284528, a Chimeric Antigen Receptor T Cell (CAR-T) Therapy Directed Against B-Cell Maturation Antigen (BCMA) in Participants With Relapsed or Refractory Multiple Myeloma
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Leukemia, Myeloid, Acute Clinical Trial
A Study Evaluating Intensive Chemotherapy With or Without Glasdegib or Azacitidine With or Without Glasdegib In Patients With Previously Untreated Acute Myeloid Leukemia
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Clinical Benefit of SAR650984, Bortezomib, Lenalidomide and Dexamethasone Combination in NDMM Patients Not Eligible for Transplant
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Fabry Disease Clinical Trial
Open Label Extension of 2 mg/kg Pegunigalsidase Alfa (PRX-102) Every 4 Weeks in Adult Fabry Disease Patients
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Hemophilia A Clinical Trial
Assessing Physician and Hemophilia A Patient Reasons and Expectations for Switching Treatment to Kovaltry: A Nested Study Within an Existing Registry
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Relapsed or Refractory Multiple Myeloma Clinical Trial
A Study of Carfilzomib Plus Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma at US Community Oncology Centers
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Relapsed or Refractory Multiple Myeloma Clinical Trial
A Study of Carfilzomib Plus Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma at US Community Oncology Centers
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Relapsed or Refractory Multiple Myeloma Clinical Trial
A Study of Carfilzomib Plus Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma at US Community Oncology Centers
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Relapsed or Refractory Multiple Myeloma Clinical Trial
A Study of Carfilzomib Plus Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma at US Community Oncology Centers
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Fabry Disease Clinical Trial
Extension Study of 1 mg/kg Pegunigalsidase Alfa in Patients With Fabry Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Chemotherapy-Induced Thrombocytopenia Clinical Trial
Avatrombopag for the Treatment of Chemotherapy-Induced Thrombocytopenia in Adults With Active Non-Hematological Cancers
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
A Study of Carfilzomib, Lenalidomide, Dexamethasone and Daratumumab for Patients With Relapsed/Refractory Myeloma With Salvage Autologous Hematopoietic Cell Transplantation
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Acute Myelogenous Leukemia Clinical Trial
Epigenetic Reprogramming in Relapse/Refractory AML
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology Clinical Trial
A Study of the Impact of Hemophilia and Its Treatment on Brain Development, Thinking and Behaviour in Children With Hemophilia
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology Clinical Trial
A Study of the Impact of Hemophilia and Its Treatment on Brain Development, Thinking and Behaviour in Children With Hemophilia
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology Clinical Trial
A Study of the Impact of Hemophilia and Its Treatment on Brain Development, Thinking and Behaviour in Children With Hemophilia
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology Clinical Trial
A Study of the Impact of Hemophilia and Its Treatment on Brain Development, Thinking and Behaviour in Children With Hemophilia
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology Clinical Trial
A Study of the Impact of Hemophilia and Its Treatment on Brain Development, Thinking and Behaviour in Children With Hemophilia
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology Clinical Trial
A Study of the Impact of Hemophilia and Its Treatment on Brain Development, Thinking and Behaviour in Children With Hemophilia
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology Clinical Trial
KRT-232 in Subjects With PMF, Post-PV MF, or Post-ET MF Who Have Failed a JAK Inhibitor
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Amyloidogenic Transthyretin (ATTR) Amyloidosis Clinical Trial
A Study of PRX004 in Subjects With Amyloid Transthyretin (ATTR) Amyloidosis
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
Allogeneic Hematopoietic Cell Transplantation for Disorders of T-cell Proliferation and/or Dysregulation
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Polycythemia Vera Clinical Trial
KRT-232 Compared to Ruxolitinib in Patients With Phlebotomy-Dependent Polycythemia Vera
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Relapsed/ Refractory Multiple Myeloma Clinical Trial
Study Evaluating AMG 424 in Subjects With Multiple Myeloma
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
AL Amyloidosis Clinical Trial
Ixazomib Maintenance Study in Patients With AL Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology Clinical Trial
ATHN 7: Hemophilia Natural History Study
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology Clinical Trial
ATHN 7: Hemophilia Natural History Study
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology Clinical Trial
ATHN 7: Hemophilia Natural History Study
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology Clinical Trial
ATHN 7: Hemophilia Natural History Study
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Other Clinical Trial
Post-Injury Platelet Biology: Mechanisms and Outcomes
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Multinational Clinical Study Comparing Isatuximab, Carfilzomib And Dexamethasone To Carfilzomib And Dexamethasone In Relapse And/Or Refractory Multiple Myeloma Patients
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Hematology Clinical Trial
Study to Evaluate the Safety and Efficacy of SPR001 in Subjects With Classic Congenital Adrenal Hyperplasia
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Hematology Clinical Trial
Study to Evaluate the Safety and Efficacy of SPR001 in Subjects With Classic Congenital Adrenal Hyperplasia
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Acute Myeloid Leukemia Clinical Trial
Efficacy and Safety of BST-236 in Newly Diagnosed Acute Myeloid Leukemia Patients, Unfit for Standard Induction Therapy
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Hematology Clinical Trial
Hyperglycemia, Exercise, and Endothelial Function
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
Ulixertinib in Treating Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With MAPK Pathway Mutations (A Pediatric MATCH Treatment Trial)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
Ulixertinib in Treating Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With MAPK Pathway Mutations (A Pediatric MATCH Treatment Trial)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Study of APVO436 in Patients With AML or MDS
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Study of APVO436 in Patients With AML or MDS
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology Clinical Trial
A Safety and Efficacy Study Evaluating CTX001 in Subjects With Severe Sickle Cell Disease
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Fabry Disease Clinical Trial
A Study to Evaluate the Long-term Safety and Tolerability of Lucerastat in Adult Subjects With Fabry Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Fabry Disease Clinical Trial
A Study to Evaluate the Long-term Safety and Tolerability of Lucerastat in Adult Subjects With Fabry Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Safety, Tolerability, Pharmacokinetics and Efficacy of AMG 397 in Subjects With Multiple Myeloma, NHL, and AML
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Hematology, Neurology, Oncology Clinical Trial
Registry for Adults With Plasma Cell Disorders (PCD's)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology Clinical Trial
A Study Following People With Haemophilia A and B, With or Without Inhibitors, When on Usual Treatment (Explorer™6)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology Clinical Trial
A Study Following People With Haemophilia A and B, With or Without Inhibitors, When on Usual Treatment (Explorer™6)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology Clinical Trial
A Study Following People With Haemophilia A and B, With or Without Inhibitors, When on Usual Treatment (Explorer™6)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology Clinical Trial
A Study Following People With Haemophilia A and B, With or Without Inhibitors, When on Usual Treatment (Explorer™6)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Study of PTC299 in Relapsed/Refractory Acute Leukemias
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Gastroenterology, Hematology, Oncology Clinical Trial
A Study of Colesevelam for Lenalidomide-Associated Diarrhea
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology, Hematology, Nephrology / Urology, Neurology, Ophthalmology, Pulmonary / Respiratory Diseases, Reproductive Clinical Trial
Collection of Whole Blood Samples for the Evaluation of Preeclampsia (Pre-E) Biomarkers From Pregnant Women
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Graft-Versus-Host-Disease Clinical Trial
Efficacy and Safety of KD025 in Subjects With cGVHD After At Least 2 Prior Lines of Systemic Therapy
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Graft-Versus-Host-Disease Clinical Trial
Efficacy and Safety of KD025 in Subjects With cGVHD After At Least 2 Prior Lines of Systemic Therapy
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Acute Myeloid Leukemia (AML) Clinical Trial
A Global Study of the Efficacy and Safety of Midostaurin + Chemotherapy in Newly Diagnosed Patients With FLT3 Mutation Negative (FLT3-MN) Acute Myeloid Leukemia (AML)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Acute Myeloid Leukemia Clinical Trial
Daunorubicin and Cytarabine With or Without Uproleselan in Treating Older Adult Patients With Acute Myeloid Leukemia Receiving Intensive Induction Chemotherapy
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Acute Myeloid Leukemia Clinical Trial
Daunorubicin and Cytarabine With or Without Uproleselan in Treating Older Adult Patients With Acute Myeloid Leukemia Receiving Intensive Induction Chemotherapy
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Acute Myeloid Leukemia Clinical Trial
Daunorubicin and Cytarabine With or Without Uproleselan in Treating Older Adult Patients With Acute Myeloid Leukemia Receiving Intensive Induction Chemotherapy
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Relapsed and/or Refractory Multiple Myeloma Clinical Trial
Assessment of AMG 420 in Subjects With Relapsed and/or Refractory Multiple Myeloma
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Acute Myeloid Leukemia Clinical Trial
A Dose Optimisation Study of ASLAN003 in Acute Myeloid Leukemia
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Acute Myeloid Leukemia Clinical Trial
Daunorubicin and Cytarabine With or Without Uproleselan in Treating Older Adult Patients With Acute Myeloid Leukemia Receiving Intensive Induction Chemotherapy
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Hemophilia Clinical Trial
Long-term Safety and Efficacy Study of Fitusiran in Patients With Hemophilia A or B, With or Without Inhibitory Antibodies to Factor VIII or IX
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Hypereosinophilic Syndrome Clinical Trial
This Record Contains Information About the Mepolizumab Compassionate Use (CU) Product Activities: 104317: CU and Long-Term Access Study of Mepolizumab in HES. 201956:A Long-term Access Programme for Subjects With Severe Asthma 112562: Expanded Access for Patients With Hypereosinophilic
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Hypereosinophilic Syndrome Clinical Trial
This Record Contains Information About the Mepolizumab Compassionate Use (CU) Product Activities: 104317: CU and Long-Term Access Study of Mepolizumab in HES. 201956:A Long-term Access Programme for Subjects With Severe Asthma 112562: Expanded Access for Patients With Hypereosinophilic
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Hypereosinophilic Syndrome Clinical Trial
This Record Contains Information About the Mepolizumab Compassionate Use (CU) Product Activities: 104317: CU and Long-Term Access Study of Mepolizumab in HES. 201956:A Long-term Access Programme for Subjects With Severe Asthma 112562: Expanded Access for Patients With Hypereosinophilic
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Hypereosinophilic Syndrome Clinical Trial
This Record Contains Information About the Mepolizumab Compassionate Use (CU) Product Activities: 104317: CU and Long-Term Access Study of Mepolizumab in HES. 201956:A Long-term Access Programme for Subjects With Severe Asthma 112562: Expanded Access for Patients With Hypereosinophilic
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology Clinical Trial
Transthyretin-Associated Amyloidoses Outcome Survey (THAOS)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
We've found
12,064 Hematology
clinical trials
Multiple Myeloma Clinical Trial
Updated: 12/31/1969
A Phase 1 Study of Ruxolitinib, Steroids and Lenalidomide for Relapsed/Refractory Multiple Myeloma (RRMM) Patients
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Updated: 12/31/1969
Clinical Evaluation of the OncAlert RAPID in Subjects Presenting for Evaluation and/or Initial Biopsy; Impact on Decision-Making
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
CAH - Congenital Adrenal Hyperplasia Clinical Trial
Updated: 12/31/1969
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of NBI-74788 in Adults With Congenital Adrenal Hyperplasia
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology Clinical Trial
Updated: 12/31/1969
A Research Study Looking at How a Factor VIII Medicine Called Turoctocog Alfa Pegol (N8-GP) Works in People With Haemophilia A
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology Clinical Trial
Updated: 12/31/1969
A Research Study Looking at How a Factor VIII Medicine Called Turoctocog Alfa Pegol (N8-GP) Works in People With Haemophilia A
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology Clinical Trial
Updated: 12/31/1969
A Research Study Looking at How a Factor VIII Medicine Called Turoctocog Alfa Pegol (N8-GP) Works in People With Haemophilia A
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology Clinical Trial
Updated: 12/31/1969
A Research Study Looking at How a Factor VIII Medicine Called Turoctocog Alfa Pegol (N8-GP) Works in People With Haemophilia A
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Updated: 12/31/1969
A Study of JNJ-68284528, a Chimeric Antigen Receptor T Cell (CAR-T) Therapy Directed Against B-Cell Maturation Antigen (BCMA) in Participants With Relapsed or Refractory Multiple Myeloma
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Leukemia, Myeloid, Acute Clinical Trial
Updated: 12/31/1969
A Study Evaluating Intensive Chemotherapy With or Without Glasdegib or Azacitidine With or Without Glasdegib In Patients With Previously Untreated Acute Myeloid Leukemia
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Updated: 12/31/1969
Clinical Benefit of SAR650984, Bortezomib, Lenalidomide and Dexamethasone Combination in NDMM Patients Not Eligible for Transplant
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Fabry Disease Clinical Trial
Updated: 12/31/1969
Open Label Extension of 2 mg/kg Pegunigalsidase Alfa (PRX-102) Every 4 Weeks in Adult Fabry Disease Patients
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Hemophilia A Clinical Trial
Updated: 12/31/1969
Assessing Physician and Hemophilia A Patient Reasons and Expectations for Switching Treatment to Kovaltry: A Nested Study Within an Existing Registry
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Relapsed or Refractory Multiple Myeloma Clinical Trial
Updated: 12/31/1969
A Study of Carfilzomib Plus Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma at US Community Oncology Centers
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Relapsed or Refractory Multiple Myeloma Clinical Trial
Updated: 12/31/1969
A Study of Carfilzomib Plus Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma at US Community Oncology Centers
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Relapsed or Refractory Multiple Myeloma Clinical Trial
Updated: 12/31/1969
A Study of Carfilzomib Plus Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma at US Community Oncology Centers
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Relapsed or Refractory Multiple Myeloma Clinical Trial
Updated: 12/31/1969
A Study of Carfilzomib Plus Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma at US Community Oncology Centers
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Fabry Disease Clinical Trial
Updated: 12/31/1969
Extension Study of 1 mg/kg Pegunigalsidase Alfa in Patients With Fabry Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Chemotherapy-Induced Thrombocytopenia Clinical Trial
Updated: 12/31/1969
Avatrombopag for the Treatment of Chemotherapy-Induced Thrombocytopenia in Adults With Active Non-Hematological Cancers
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Updated: 12/31/1969
A Study of Carfilzomib, Lenalidomide, Dexamethasone and Daratumumab for Patients With Relapsed/Refractory Myeloma With Salvage Autologous Hematopoietic Cell Transplantation
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Acute Myelogenous Leukemia Clinical Trial
Updated: 12/31/1969
Epigenetic Reprogramming in Relapse/Refractory AML
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology Clinical Trial
Updated: 12/31/1969
A Study of the Impact of Hemophilia and Its Treatment on Brain Development, Thinking and Behaviour in Children With Hemophilia
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology Clinical Trial
Updated: 12/31/1969
A Study of the Impact of Hemophilia and Its Treatment on Brain Development, Thinking and Behaviour in Children With Hemophilia
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology Clinical Trial
Updated: 12/31/1969
A Study of the Impact of Hemophilia and Its Treatment on Brain Development, Thinking and Behaviour in Children With Hemophilia
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology Clinical Trial
Updated: 12/31/1969
A Study of the Impact of Hemophilia and Its Treatment on Brain Development, Thinking and Behaviour in Children With Hemophilia
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology Clinical Trial
Updated: 12/31/1969
A Study of the Impact of Hemophilia and Its Treatment on Brain Development, Thinking and Behaviour in Children With Hemophilia
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology Clinical Trial
Updated: 12/31/1969
A Study of the Impact of Hemophilia and Its Treatment on Brain Development, Thinking and Behaviour in Children With Hemophilia
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology Clinical Trial
Updated: 12/31/1969
KRT-232 in Subjects With PMF, Post-PV MF, or Post-ET MF Who Have Failed a JAK Inhibitor
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Amyloidogenic Transthyretin (ATTR) Amyloidosis Clinical Trial
Updated: 12/31/1969
A Study of PRX004 in Subjects With Amyloid Transthyretin (ATTR) Amyloidosis
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
Updated: 12/31/1969
Allogeneic Hematopoietic Cell Transplantation for Disorders of T-cell Proliferation and/or Dysregulation
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Polycythemia Vera Clinical Trial
Updated: 12/31/1969
KRT-232 Compared to Ruxolitinib in Patients With Phlebotomy-Dependent Polycythemia Vera
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Relapsed/ Refractory Multiple Myeloma Clinical Trial
Updated: 12/31/1969
Study Evaluating AMG 424 in Subjects With Multiple Myeloma
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
AL Amyloidosis Clinical Trial
Updated: 12/31/1969
Ixazomib Maintenance Study in Patients With AL Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology Clinical Trial
Updated: 12/31/1969
ATHN 7: Hemophilia Natural History Study
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology Clinical Trial
Updated: 12/31/1969
ATHN 7: Hemophilia Natural History Study
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology Clinical Trial
Updated: 12/31/1969
ATHN 7: Hemophilia Natural History Study
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology Clinical Trial
Updated: 12/31/1969
ATHN 7: Hemophilia Natural History Study
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
Updated: 12/31/1969
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
Updated: 12/31/1969
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
Updated: 12/31/1969
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
Updated: 12/31/1969
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
Updated: 12/31/1969
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
Updated: 12/31/1969
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
Updated: 12/31/1969
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
Updated: 12/31/1969
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
Updated: 12/31/1969
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
Updated: 12/31/1969
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
Updated: 12/31/1969
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
Updated: 12/31/1969
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Other Clinical Trial
Updated: 12/31/1969
Post-Injury Platelet Biology: Mechanisms and Outcomes
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Updated: 12/31/1969
Multinational Clinical Study Comparing Isatuximab, Carfilzomib And Dexamethasone To Carfilzomib And Dexamethasone In Relapse And/Or Refractory Multiple Myeloma Patients
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Hematology Clinical Trial
Updated: 12/31/1969
Study to Evaluate the Safety and Efficacy of SPR001 in Subjects With Classic Congenital Adrenal Hyperplasia
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Hematology Clinical Trial
Updated: 12/31/1969
Study to Evaluate the Safety and Efficacy of SPR001 in Subjects With Classic Congenital Adrenal Hyperplasia
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Acute Myeloid Leukemia Clinical Trial
Updated: 12/31/1969
Efficacy and Safety of BST-236 in Newly Diagnosed Acute Myeloid Leukemia Patients, Unfit for Standard Induction Therapy
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Hematology Clinical Trial
Updated: 12/31/1969
Hyperglycemia, Exercise, and Endothelial Function
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
Updated: 12/31/1969
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
Updated: 12/31/1969
Ulixertinib in Treating Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With MAPK Pathway Mutations (A Pediatric MATCH Treatment Trial)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
Updated: 12/31/1969
Ulixertinib in Treating Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With MAPK Pathway Mutations (A Pediatric MATCH Treatment Trial)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Updated: 12/31/1969
Study of APVO436 in Patients With AML or MDS
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Updated: 12/31/1969
Study of APVO436 in Patients With AML or MDS
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology Clinical Trial
Updated: 12/31/1969
A Safety and Efficacy Study Evaluating CTX001 in Subjects With Severe Sickle Cell Disease
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Fabry Disease Clinical Trial
Updated: 12/31/1969
A Study to Evaluate the Long-term Safety and Tolerability of Lucerastat in Adult Subjects With Fabry Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Fabry Disease Clinical Trial
Updated: 12/31/1969
A Study to Evaluate the Long-term Safety and Tolerability of Lucerastat in Adult Subjects With Fabry Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Updated: 12/31/1969
Safety, Tolerability, Pharmacokinetics and Efficacy of AMG 397 in Subjects With Multiple Myeloma, NHL, and AML
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Hematology, Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Registry for Adults With Plasma Cell Disorders (PCD's)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology Clinical Trial
Updated: 12/31/1969
A Study Following People With Haemophilia A and B, With or Without Inhibitors, When on Usual Treatment (Explorer™6)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology Clinical Trial
Updated: 12/31/1969
A Study Following People With Haemophilia A and B, With or Without Inhibitors, When on Usual Treatment (Explorer™6)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology Clinical Trial
Updated: 12/31/1969
A Study Following People With Haemophilia A and B, With or Without Inhibitors, When on Usual Treatment (Explorer™6)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology Clinical Trial
Updated: 12/31/1969
A Study Following People With Haemophilia A and B, With or Without Inhibitors, When on Usual Treatment (Explorer™6)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Updated: 12/31/1969
Study of PTC299 in Relapsed/Refractory Acute Leukemias
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Gastroenterology, Hematology, Oncology Clinical Trial
Updated: 12/31/1969
A Study of Colesevelam for Lenalidomide-Associated Diarrhea
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology, Hematology, Nephrology / Urology, Neurology, Ophthalmology, Pulmonary / Respiratory Diseases, Reproductive Clinical Trial
Updated: 12/31/1969
Collection of Whole Blood Samples for the Evaluation of Preeclampsia (Pre-E) Biomarkers From Pregnant Women
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Graft-Versus-Host-Disease Clinical Trial
Updated: 12/31/1969
Efficacy and Safety of KD025 in Subjects With cGVHD After At Least 2 Prior Lines of Systemic Therapy
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Graft-Versus-Host-Disease Clinical Trial
Updated: 12/31/1969
Efficacy and Safety of KD025 in Subjects With cGVHD After At Least 2 Prior Lines of Systemic Therapy
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Acute Myeloid Leukemia (AML) Clinical Trial
Updated: 12/31/1969
A Global Study of the Efficacy and Safety of Midostaurin + Chemotherapy in Newly Diagnosed Patients With FLT3 Mutation Negative (FLT3-MN) Acute Myeloid Leukemia (AML)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Acute Myeloid Leukemia Clinical Trial
Updated: 12/31/1969
Daunorubicin and Cytarabine With or Without Uproleselan in Treating Older Adult Patients With Acute Myeloid Leukemia Receiving Intensive Induction Chemotherapy
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Acute Myeloid Leukemia Clinical Trial
Updated: 12/31/1969
Daunorubicin and Cytarabine With or Without Uproleselan in Treating Older Adult Patients With Acute Myeloid Leukemia Receiving Intensive Induction Chemotherapy
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Acute Myeloid Leukemia Clinical Trial
Updated: 12/31/1969
Daunorubicin and Cytarabine With or Without Uproleselan in Treating Older Adult Patients With Acute Myeloid Leukemia Receiving Intensive Induction Chemotherapy
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Relapsed and/or Refractory Multiple Myeloma Clinical Trial
Updated: 12/31/1969
Assessment of AMG 420 in Subjects With Relapsed and/or Refractory Multiple Myeloma
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Acute Myeloid Leukemia Clinical Trial
Updated: 12/31/1969
A Dose Optimisation Study of ASLAN003 in Acute Myeloid Leukemia
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Acute Myeloid Leukemia Clinical Trial
Updated: 12/31/1969
Daunorubicin and Cytarabine With or Without Uproleselan in Treating Older Adult Patients With Acute Myeloid Leukemia Receiving Intensive Induction Chemotherapy
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Hemophilia Clinical Trial
Updated: 12/31/1969
Long-term Safety and Efficacy Study of Fitusiran in Patients With Hemophilia A or B, With or Without Inhibitory Antibodies to Factor VIII or IX
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Hypereosinophilic Syndrome Clinical Trial
Updated: 12/31/1969
This Record Contains Information About the Mepolizumab Compassionate Use (CU) Product Activities: 104317: CU and Long-Term Access Study of Mepolizumab in HES. 201956:A Long-term Access Programme for Subjects With Severe Asthma 112562: Expanded Access for Patients With Hypereosinophilic
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Hypereosinophilic Syndrome Clinical Trial
Updated: 12/31/1969
This Record Contains Information About the Mepolizumab Compassionate Use (CU) Product Activities: 104317: CU and Long-Term Access Study of Mepolizumab in HES. 201956:A Long-term Access Programme for Subjects With Severe Asthma 112562: Expanded Access for Patients With Hypereosinophilic
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Hypereosinophilic Syndrome Clinical Trial
Updated: 12/31/1969
This Record Contains Information About the Mepolizumab Compassionate Use (CU) Product Activities: 104317: CU and Long-Term Access Study of Mepolizumab in HES. 201956:A Long-term Access Programme for Subjects With Severe Asthma 112562: Expanded Access for Patients With Hypereosinophilic
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Hypereosinophilic Syndrome Clinical Trial
Updated: 12/31/1969
This Record Contains Information About the Mepolizumab Compassionate Use (CU) Product Activities: 104317: CU and Long-Term Access Study of Mepolizumab in HES. 201956:A Long-term Access Programme for Subjects With Severe Asthma 112562: Expanded Access for Patients With Hypereosinophilic
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Updated: 12/31/1969
Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Updated: 12/31/1969
Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology Clinical Trial
Updated: 12/31/1969
Transthyretin-Associated Amyloidoses Outcome Survey (THAOS)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials